Fluvoxamine-induced neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is an uncommon but life-threatening idiosyncratic drug reaction that occurs following neuroleptic drug exposure. The estimated incidence of NMS is though very low, resulting mortality rates range between 4% and 30%. There is increasing evidence that “Atypical” an...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Серія: | Journal of the Scientific Society |
| Предмети: | |
| Онлайн доступ: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2017;volume=44;issue=3;spage=161;epage=162;aulast=Bellad |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|